3842-68-0Relevant academic research and scientific papers
Self-assembly of a cavitand-based capsule by dynamic boronic ester formation
Nishimura, Naoki,Kobayashi, Kenji
, p. 6255 - 6258 (2008)
Be my guest: Two molecules of a cavitand tetraboronic acid and four molecules of a bis(catechol) linker quantitatively assemble into a capsule (see picture for two views), with highly selective guest-recognition, by dynamic boronic ester formation. The on
Total synthesis of the marine metabolite (±)-Polysiphenol via highly regioselective intramolecular oxidative coupling
Barrett, Tim N.,Braddock, D. Christopher,Monta, Anna,Webb, Michael R.,White, Andrew J.P.
, p. 1980 - 1984 (2011/11/11)
(±)-Polysiphenol (1), an atropisomerically stable 4,5-dibrominated 9,10-dihydrophenanthrene from Polysiphonia ferulacea, was prepared by a biomimetically inspired highly regioselective intramolecular oxidative coupling of a dibrominated dihydrostilbene. T
Bromophenols as Candida albicans isocitrate lyase inhibitors
Oh, Ki-Bong,Jeon, Heung Bae,Han, Yu-Ri,Lee, Yeon-Ju,Park, Jiyoung,Lee, So-Hyoung,Yang, Dongsik,Kwon, Mihyun,Shin, Jongheon,Lee, Hyi-Seung
scheme or table, p. 6644 - 6648 (2010/12/19)
A new series of bromophenols was synthesized by reactions of corresponding phenol analogs with bromine. The synthesized compounds were tested for inhibitory activity against isocitrate lyase (ICL) of Candida albicans and antimicrobial activity against Gram-positive and, Gram-negative bacteria and fungi. Among the synthesized bromophenols, bis(3-bromo-4,5-dihydroxyphenyl) methanone (11) and (3-bromo-4,5-dihydroxyphenyl)(2,3-dibromo-4,5- dihydroxyphenyl)methanone (12) displayed potent inhibitory activities against ICL, showing a stronger inhibitory effects than were found with natural bromophenol 1. The preliminary structure-activity relationships were investigated in order to determine the essential structural requirements for the inhibitory activities of these compounds against ICL of C. albicans.
COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
-
Page 30, (2008/06/13)
Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially A? amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinophathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
